Category : IBD

(27 February 2013) Although considerable progress has been made in determining the impact of the gut microbiota on the development of inflammatory bowel disease (IBD) and other gastrointestinal (GI) diseases, the detailed study and understanding of the composition and effects of this intestinal community still faces numerous methodological and empirical challenges. “Improvement of study design and sample collection, as well…

GMFH Editing Team
GMFH Editing Team

(27 February 2013) Although considerable progress has been made in determining the impact of the gut microbiota on the development of inflammatory bowel disease (IBD) and other gastrointestinal (GI) diseases, the detailed study and understanding of the composition and effects of this intestinal community still faces numerous methodological and empirical challenges. “Improvement of study design and sample collection, as well…

GMFH Editing Team
GMFH Editing Team

Scientists from Brussels University noticed recently in a recent published article that enterotypes could be found also in mice model whatever the genetic background. Although genetic and environmental factor have to be taken in account during any experiment with mice, authors also said that mice enterotypes have also to be controlled. The two first authors of this study, Falk Hildebrand…

GMFH Editing Team
GMFH Editing Team

Scientists from Brussels University noticed recently in a recent published article that enterotypes could be found also in mice model whatever the genetic background. Although genetic and environmental factor have to be taken in account during any experiment with mice, authors also said that mice enterotypes have also to be controlled. The two first authors of this study, Falk Hildebrand…

GMFH Editing Team
GMFH Editing Team

Speakers: Peter Lakatos (Hungary), Sheila Crowe (USA) Bone mineral disease (BMD) is common in the general population, and there is an increased risk of developing disorders of BMD – osteopenia and osteoporosis – among people with gastrointestinal (GI) disorders, especially in those with inflammatory bowel disease (IBD), untreated celiac disease, end-stage cholestatic liver disease and after gastric surgery. Dr Peter…

GMFH Editing Team
GMFH Editing Team

Speakers: Peter Lakatos (Hungary), Sheila Crowe (USA) Bone mineral disease (BMD) is common in the general population, and there is an increased risk of developing disorders of BMD – osteopenia and osteoporosis – among people with gastrointestinal (GI) disorders, especially in those with inflammatory bowel disease (IBD), untreated celiac disease, end-stage cholestatic liver disease and after gastric surgery. Dr Peter…

GMFH Editing Team
GMFH Editing Team

Speakers: Franck Carbonnel (France), Johan Burisch (Denmark), Fergus Shanahan (Ireland) The role of gut microbiota in the pathogenesis of inflammatory bowel disease (IBD) is increasingly recognised, as evidenced by the escalating number of publications on microbiota, rising from less than 200 in 1990 to over 1200 in 2012 thus far. This fact was highlighted by Dr Fergus Shanahan when introducing…

GMFH Editing Team
GMFH Editing Team

Speakers: Franck Carbonnel (France), Johan Burisch (Denmark), Fergus Shanahan (Ireland) The role of gut microbiota in the pathogenesis of inflammatory bowel disease (IBD) is increasingly recognised, as evidenced by the escalating number of publications on microbiota, rising from less than 200 in 1990 to over 1200 in 2012 thus far. This fact was highlighted by Dr Fergus Shanahan when introducing…

GMFH Editing Team
GMFH Editing Team

MetaHIT (METAgenomics of the Human Intestinal Tract) is a collaborative project, funded by the European Commission, gathering 15 institutes from 8 countries. It was born of the idea that, with the rapid development of sequencing technologies, researchers could imagine explore the genetic potential of human microbial companions and understand their impact on our health and well being. The microbes of the…

GMFH Editing Team
GMFH Editing Team

MetaHIT (METAgenomics of the Human Intestinal Tract) is a collaborative project, funded by the European Commission, gathering 15 institutes from 8 countries. It was born of the idea that, with the rapid development of sequencing technologies, researchers could imagine explore the genetic potential of human microbial companions and understand their impact on our health and well being. The microbes of the…

GMFH Editing Team
GMFH Editing Team